Home > Cashflow Statement > TRIDENT LIFELINE

TRIDENT LIFELINE
Cashflow Statement

COMMUNITY POLL
for TRIDENT LIFELINE
Please provide your vote to see the results

TRIDENT LIFELINE Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023Mar2022
Profit Before Tax₹8.70 Cr₹6.58 Cr₹2.98 Cr
Adjustment ₹0.12 Cr₹0.08 Cr₹0.33 Cr
Changes In working Capital ₹-4.20 Cr₹-25 Cr₹-3.67 Cr
Cash Flow after changes in Working Capital ₹4.61 Cr₹-18 Cr₹-0.36 Cr
Cash Flow from Operating Activities ₹2.23 Cr₹-19 Cr₹-0.21 Cr
Cash Flow from Investing Activities ₹-20 Cr₹-9.69 Cr₹-0.45 Cr
Cash Flow from Financing Activities ₹11 Cr₹42 Cr₹0.80 Cr
Net Cash Inflow / Outflow ₹-7.13 Cr₹14 Cr₹0.14 Cr
Opening Cash & Cash Equivalents ₹14 Cr₹0.18 Cr₹0.01 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger ---
Cash & Cash Equivalent of Subsidiaries under liquidations ---
Translation adjustment on reserves / op cash balalces frgn subsidiaries ---
Effect of Foreign Exchange Fluctuations ---
Closing Cash & Cash Equivalent ₹6.65 Cr₹14 Cr₹0.16 Cr

Compare Cashflow Statement of peers of TRIDENT LIFELINE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TRIDENT LIFELINE ₹330.2 Cr 3.7% 1.1% 69.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,519.0 Cr 0.3% -4.9% 15.8% Stock Analytics
DIVIS LABORATORIES ₹175,903.0 Cr 0.2% 10% 53.5% Stock Analytics
CIPLA ₹121,669.0 Cr 2.3% 1.1% 2.6% Stock Analytics
DR REDDYS LABORATORIES ₹110,097.0 Cr 5.7% 15% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,605.0 Cr 0.8% -0.9% 17.4% Stock Analytics


TRIDENT LIFELINE Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TRIDENT LIFELINE

3.7%

1.1%

69.5%

SENSEX

1.3%

2.6%

7.8%


You may also like the below Video Courses